|
| |
|
| |
 |
Corporate
Film |
 |
| |
Corporate
Presentation |
|
| |
|
Corporate
Gallery |
 |
|
| |
|
|
|
|
| |
|
|
|
| |
 |
| |
Focus Areas |
> |
Diseases Segment |
|
| |
| |
Shantha has
targeted Infectious Diseases and Oncology as its primary areas
of interest for conducting R&D activities. |
|
| |
|
|
| |
Infectious Diseases: |
|
| |
| |
| |
• |
ID’s are the
most common cause of mortality in children below 5 years
of age |
| |
• |
Early vaccination can eradicate
the outbreak of IDs. |
| |
• |
Shantha regards the research
and development of safe and cost-effective vaccines
that will prevent the outbreak of IDs as a social responsibility
and a moral obligation. |
|
|
| |
|
|
| |
Oncology |
|
| |
| |
| |
• |
An extensive amount
of innovative research is conducted in this field, rendering
it a fertile area for the development of novel therapies. |
| |
• |
Cancer being the fourth largest
killer in the work, there are a large number of terminally
ill patients who can be helped by new therapeutic proteins
and monoclonals |
|
|
|